Biotech Blog Archives: February 2005
next page ·
28 February 2005
Biotech Buyout Binge Continues
For the second week in a row, buyout rumors and merger speculation sent a number of biotech and specialty pharmaceutical shares higher.
continue reading... » 0 Comments
25 February 2005
Ad Changes Ahead for Controversial Drugs
Ad executives and drug company officials say changes in advertising strategies are almost a certainty in the wake of the Vioxx and Celebrex news and new studies showing a consumer backlash.
continue reading... » 0 Comments
22 February 2005
Drug Patent Approvals
Newsletters alert you to new drug patent approvals.
continue reading... » 0 Comments
22 February 2005
U.N. Calls for Clone Ban
The United Nations has called on countries to ban all forms of human cloning “incompatable with human dignity.” The American religious right claims victory, but others say the declaration is the result of political maneuvering influenced by pressure from the United States.
continue reading... » 0 Comments
19 February 2005
Will California’s Stem Cell Initiative Reap Royalties?
When the backers of California’s stem cell initiative were seeking voter support last year, they not only promised cures for dread diseases, but also licensing revenue for the state. A statement posted on the initiative proponents’ CuresforCalifornia.com Web site says that ‘California will benefit for decades from patents and royalties that result from the research.’ [...]
continue reading... » 0 Comments
16 February 2005
FDA Plans New Board To Monitor Drug Safety
The Food and Drug Administration will create an independent board to more aggressively monitor the safety of drugs on the market as part of an effort to restore public confidence in the nation’s prescription drug supply, Health and Human Services Secretary Mike Leavitt announced yesterday.
